Advanced search
Publication Cover
Cogent Medicine Volume 3, 2016 - Issue 1
Journal homepage
1,314
Views
8
CrossRef citations to date
0
Altmetric
Review Article

Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement

Simon AllenDepartment of Health, Fine Treatment, 29 Rewley Road, OxfordOX1 2RA, UKCorrespondence[email protected] [email protected]
View further author information
&
Ivan Gerasimovich AghajanyanDepartment of Urology, Yerevan State Medical University, 9 Ezras Hasratyan St, Yerevan0052, Republic of ArmeniaORCID Iconhttps://orcid.org/0000-0002-3851-3763View further author information
ORCID Icon |
Udo SchumacherUniversity Medical Center Hamburg-Eppendorf, GermanyView further author information
(Reviewing Editor)
Article: 1195067 | Received 15 Apr 2016, Accepted 24 May 2016, Published online: 29 Jun 2016

References

  • Abrams, P., Chapple, C., Khoury, S., Roehrborn, C., & de la Rosette, J. (2009). Evaluation and treatment of lower urinary tract symptoms in older men. The Journal of Urology, 181, 1779–1787.10.1016/j.juro.2008.11.127
  • Aggarwal, S., Verma, A., Shukla, R., Batra, S., Bhardwaj, T., & Kumar, M. (2014). An overview of phytotherapeutic approaches for the treatment of benign prostatic hyperplasia. Mini-Reviews in Medicinal Chemistry, 14, 257–270.10.2174/1389557514666140123124321
  • Aghajanyan, I. G., & Allen, S. (2016). Positive response to thermobalancing therapy enabled by therapeutic device in men with non-malignant prostate diseases: BPH and chronic prostatitis. Diseases, 4, 18.10.3390/diseases4020018
  • Allen, S., & Adjani, A. (2009). Therapeutic Device and Method, US 20110152986 A1. Retrieved from http://www.google.com/patents/US20110152986
  • Allen, S., & Aghajanyan, I. G. (2015, November 14). Benign prostatic hyperplasia treatment with new physiotherapeutic device. Urology Journal, 12, 2371–2376.
  • American Urological Association (AUA). (2015). Guideline on the management of Benign Prostatic Hyperplasia. Retrieved from https://www.auanet.org/education/guidelines/benign-prostatic-hyperplasia.cfm.
  • Brown, C. T., & Emberton, M. (2009). Self-management for men with lower urinary tract symptoms. Current Urology Reports, 10, 261–266.10.1007/s11934-009-0043-6
  • Corona, G., Vignozzi, L., Rastrelli, G., Lotti, F., Cipriani, S., & Maggi, M. (2014). Benign prostatic hyperplasia: A new metabolic disease of the aging male and its correlation with sexual dysfunctions. International Journal of Endocrinology, 2014, 2014:329456.
  • Elshal, A. M., Elmansy, H. M., Elkoushy, M. A., & Elhilali, M. M. (2012). Male sexual function outcome after three laser prostate surgical techniques: A single center perspective. Urology, 80, 1098–1104.10.1016/j.urology.2012.08.001
  • Fourcade, R. O., Lacoin, F., Rouprêt, M., Slama, A., Le Fur, C., Michel, E., … Cotté, F. E. (2012). Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World Journal of Urology, 30, 419–426.10.1007/s00345-011-0756-2
  • Gacci, M., Ficarra, V., Sebastianelli, A., Corona, G., Serni, S., Shariat S. F., ... Novara, G. (2015). Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU International, 115, 24–31.10.1111/bju.12728
  • Gacci, M., Ficarra, V., Sebastianelli, A., Corona, G., Serni, S., Shariat, S., … Novara, G. (2014). Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: A systematic review and meta-analysis. The Journal of Sexual Medicine, 11, 1554–1566.10.1111/jsm.12525
  • Gravas, S., Bach, T., Bachmann, A., Drake, M., Gacci, M., Gratzke, C. ... Tikkinen, K. (2015). Guidelines on the management of non-neurogenic male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). The European Association of Urology (EAU) Guidelines.
  • Johnson, T. M. Markland, A. D., & Goode, P. S. (2013 Jul). Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α-blocker therapy in men with nocturia. BJU International, 112, 100–108.10.1111/j.1464-410X.2012.11736.x
  • Naeem, B., Giorgio, G., Akshay, S., Arun, R., Daniel, P., Steven, L. C., & Pierre I. K. (2014). Morbidity and mortality after benign prostatic hyperplasia surgery: Data from the american college of surgeons national surgical quality improvement program. Journal of Endourology, 28, 831–840.
  • Oelke, M., Bachmann, A., Descazeaud, A., Emberton, M., Gravas, S., Michel, M. C., ... de la Rosette, J. J. (2010). Guidelines on conservative treatment of non-neurogenic male LUTS. The European Association of Urology (EAU) Guidelines.
  • Pinto, J. D., He, H. G., Chan, S. W., & Wang, W. (2016, January 19). Health-related quality of life and psychological well-being in men with benign prostatic hyperplasia: An integrative review. Japan Journal of Nursing Science,1-15. doi:10.1111/jjns.12115.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.